Measure of public health prepardeness in respect of APIs / intermediate / KSMs which are closely monitor the production and availability of APIs and their formulations to prevent black marketing and hoarding.
Drug controller cum licensing authority, director of health services, Chandigarh are monitoring for availability of APIs and drugs in context of outbreak of COVID-19 in China. NPPA (National Pharmaceutical pricing authority) chairman had written a letter to Drug Controller, Chandigarh and all the other State's/ UTs Chief Secretaries for taking measures on price control due to COVID-19 outbreak in the country.
source https://www.pharmatutor.org/pharma-news/2020/health-services-monitoring-for-price-hike-due-to-covid-19-in-india
No comments:
Post a Comment